Literature DB >> 7005985

[Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].

F Smaltino, R Ciccarelli, S Cirillo, T D'Auria, A Gambardella, G La Tessa, S Meoli, A Rotondo, S Santoro.   

Abstract

This is a report of myelography findings obtained in 50 patients with B 15000 (Iopamidol), a new non ionic water-soluble contrast medium. The procedure was easily carried out with a tilting table wired to a TV image amplifier. The dose of contrast medium injected intrathecally was 10 divided by 15 cm3 of a preconstituted solution containing iodine 200 or 300 mg/cm3. There were no accidents or major complications. The myelograms obtained with the test material afforded accurate diagnosis of intramedullary and extramedullary lesions, and signally of intervertebral disk protrusion and hernia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005985

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  3 in total

1.  Adverse side effects of metrizamide and iopamidolo in myelography.

Authors:  A Carella; F Federico; F Di Cuonzo; E Vinjau; P Lamberti
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

2.  Cervical myelography with iopamidolo.

Authors:  G Belloni; G Bonaldi; L Moschini; N Quilici
Journal:  Neuroradiology       Date:  1981-03       Impact factor: 2.804

3.  Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.

Authors:  P Bassi; A Cecchini; P Dettori; E Signorini
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.